Characteristics of the NAFLD cohort
| Clinical characteristic | Mild NAFLD fibrosis (F0–2) n=14 | Advanced NAFLD fibrosis (F3–F4) n=12 | p Value |
|---|---|---|---|
| Age (years) | 57±7 | 59±12 | 0.56* |
| Gender (male) | 29% | 67% | 0.052† |
| BMI (kg/m2) | 36.0±5.5 | 36.0±7.3 | 0.996* |
| Diabetes | 50% | 67% | 0.39† |
| ALT (IU/L) | 55±37 | 62±19 | 0.55* |
| AST (IU/L) | 39±13 | 53±12 | 0.01* |
| ALB (g/L) | 46±3 | 45±4 | 0.37* |
| Platelets (×109/L) | 234±54 | 223±70 | 0.67* |
| AST/ALT ratio | 0.80±0.23 | 0.91±0.27 | 0.29* |
| NAFLD fibrosis score | −0.87±0.95 | −0.34±1.14 | 0.22* |
Data expressed as mean±SD or median (range).
*Student's t test.
†χ2 test.
ALB, albumin; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; NAFLD, non-alcoholic fatty liver disease.